Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Follow up complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I clinical trial to evaluate the safety and immunogenicity of PENNVAX-GP (gag, pol, env) vaccine, with or without IL-12 DNA plasmid, delivered via intradermal (ID) or intramuscular (IM) electroporation in healthy, HIV-1 uninfected adult participants
Description
HVTN 098 is a Phase I clinical trial to evaluate the safety and immunogenicity of PENNVAX-B with or without IL-12 DNA plasmid administered via different routes using electroporation.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.